Wells Fargo & Company Seagen Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $1.59 Million - $1.79 Million	-8,282 Reduced 9.51%	78,786 $16.7 Million
Q2 2023 Aug 15, 2023	SELL	$187.64 - $206.25 $5.34 Million - $5.87 Million	-28,484 Reduced 24.65%	87,068 $16.8 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $2.48 Million - $3.95 Million	-19,462 Reduced 14.41%	115,552 $23.4 Million
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $2.4 Million - $2.85 Million	-20,490 Reduced 13.18%	135,014 $17.4 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $169,222 - $225,317	1,251 Added 0.81%	155,504 $21.3 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $2.58 Million - $4.25 Million	23,725 Added 18.18%	154,253 $27.3 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $1.45 Million - $1.92 Million	12,143 Added 10.26%	130,528 $18.8 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $23.5 Million - $31.4 Million	-164,672 Reduced 58.18%	118,385 $18.3 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $10.4 Million - $12.4 Million	73,176 Added 34.87%	283,057 $48.1 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $23 Million - $27.4 Million	-170,147 Reduced 44.77%	209,881 $33.1 Million
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $1.69 Million - $2.34 Million	-12,258 Reduced 3.12%	380,028 $52.8 Million
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $64.6 Million - $83.1 Million	392,286 New	392,286 $68.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.